23 Jul, 2026
According to Straits Research, the global insulin patch pump market size was valued at $1,249.48 million in 2025 and is projected to grow from $1,356.93 million in 2026 to $2,625.4 million by 2034 at a CAGR of 8.6% during the forecast period 2026-2034.
An insulin patch pump is a small, wearable device designed to deliver insulin to people with diabetes. Unlike traditional pumps that are typically worn on a belt or in a pocket, an insulin patch pump is discreetly worn on the skin. The patch is about the size of a credit card and uses a cannula to deliver insulin continuously through the skin.
This patch pump is designed to improve convenience for individuals who need continuous insulin delivery but want something more compact and comfortable than traditional options. It can be programmed to deliver basal (background) insulin and bolus (meal-related) insulin doses, and some models also offer features like personalized delivery schedules.
The increasing demand for discreet and user-friendly insulin delivery systems is shifting the focus from traditional methods to more advanced, convenient solutions such as insulin patch pumps. These devices feature tubeless, wearable designs that eliminate the need for multiple daily injections, offering enhanced convenience and improved patient adherence.
Devices like CeQur Simplicity and Insulet’s Omnipod 5 are examples of this trend, offering seamless insulin delivery with minimal user effort. They allow patients to manage their diabetes without interrupting their daily activities. The compact and automated features of these systems ensure efficient, discreet insulin delivery, giving users greater freedom and flexibility.
This growing preference for convenience and an active lifestyle, combined with the integration of advanced technology, is driving significant market growth.
The integration of insulin patch pumps with digital health platforms is opening up new possibilities for remote diabetes management. These collaborations improve patient adherence and assist healthcare providers by offering real-time insulin tracking, automatic data sharing, and the ability for remote consultations.
As telemedicine and digital health solutions continue to gain traction, companies utilizing these integrations have the opportunity to broaden their market presence and deliver more patient-focused diabetes care solutions globally.
North America holds a dominant position in the global insulin patch pump market, driven by its robust healthcare infrastructure and increasing awareness of advanced diabetes management tools. The Centers for Disease Control and Prevention (CDC) reports that 37.3 million Americans are diagnosed with diabetes, contributing to a significant demand for effective insulin delivery systems. This region benefits from the widespread adoption of wearable, tubeless pumps, which align with patient preferences for convenience and mobility.
sales@straitsresearch.com